title: Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.
abstract: This document has been developed by a group of Italian diabetologists with extensive experience in continuous subcutaneous insulin infusion (CSII) therapy to provide indications for the clinical management of CSII in diabetic patients (both type 1 and type 2) based on delivery mode operating in Italy. Although the potential benefits of pump therapy in achieving glycemic goals is now accepted, such results cannot be obtained without specific knowledge and skills being conveyed to patients during ad hoc educational training. To ensure that these new technologies reach their full effectiveness, as demonstrated theoretically and clinically, a careful assessment of the overall therapeutic and educational process is required, in both qualitative and quantitative terms. Therefore, to ensure the cost-effectiveness of insulin pump therapy and to justify reimbursement of therapy costs by the National Health System in Italy, in this article we present a model for diabetes and healthcare centers to follow that provides for different levels of expertise in the field of CSII therapy. This model will guarantee the provision of excellent care during insulin pump therapies, thus representing the basis for a successful outcome and expansion of this form of insulin treatment in patients with diabetes while also keeping costs under control.
authors.affiliation: Department of Endocrinology and Diabetes, University Campus Bio Medico, Rome, Italy.
authors.forename: Anna R
authors.initials: AR
authors.lastname: Maurizi
authors.affiliation: Diabetes Unit, Sandro Pertini Hospital, Rome, Italy.
authors.forename: Concetta
authors.initials: C
authors.lastname: Suraci
authors.affiliation: Department of Systems Medicine, Catholic University School of Medicine, Rome, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Pitocco
authors.affiliation: Division of Endocrinology and Diabetes, Bambino Gesù Children's Hospital, Rome, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Schiaffini
authors.affiliation: Diabetes Unit, San Camillo-Forlanini Hospital, Rome, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Tubili
authors.affiliation: Diabetes Unit, San Camillo-Forlanini Hospital, Rome, Italy.
authors.forename: Lelio
authors.initials: L
authors.lastname: Morviducci
authors.affiliation: Diabetes Unit, Santo Spirito Hospital, Rome, Italy.
authors.forename: Renato
authors.initials: R
authors.lastname: Giordano
authors.affiliation: Department of Endocrinology and Diabetes, University Campus Bio Medico, Rome, Italy.
authors.forename: Silvia
authors.initials: S
authors.lastname: Manfrini
authors.affiliation: Department of Internal Medicine, University "Tor Vergata", Rome, Italy.
authors.forename: Davide
authors.initials: D
authors.lastname: Lauro
authors.affiliation: Department of Internal Medicine, University "Tor Vergata", Rome, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Frontoni
authors.affiliation: Department of Endocrinology and Diabetes, University Campus Bio Medico, Rome, Italy.|Centre of Diabetes, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
authors.forename: Paolo
authors.initials: P
authors.lastname: Pozzilli
authors.affiliation: Department of Experimental Medicine, University Sapienza, Rome, Italy.
authors.forename: Raffaella
authors.initials: R
authors.lastname: Buzzetti
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D019468:Disease Management; D019983:Guideline Adherence; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D007558:Italy / Q000453:epidemiology; D010818:Practice Patterns, Physicians'
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: continuous subcutaneous insulin infusion; diabetes management; insulin pump therapy; multidisciplinary insulin pump team; 多学科胰岛素泵团队; 持续皮下胰岛素输注; 糖尿病管理; 胰岛素泵治疗